scPharmaceuticals, Inc.scPharmaceuticals, Inc.scPharmaceuticals, Inc.

scPharmaceuticals, Inc.

No trades
See on Supercharts

Fundamentals and stats

Key facts

Market capitalization
Founded
CEO
Website
About

scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. The firm's products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
2SX has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company